Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments

摘要

The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.